The Philips ICE Registry-ICE-Guided Cardiac Interventional Percutaneous Procedures

Overview

About this study

The purpose of this study is to demonstrate the performance and safety of intracardiac echocardiography (ICE) system to guide cardiac interventional percutaneous procedures when used according to its instructions for use (IFU) in standard clinical practice.

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patient age is 18 years and older.
  • Patient is willing and capable of providing written informed consent.
  • Patients scheduled for a procedure who have clinical indication for ICE and in compliance with IFU.

Exclusion Criteria:

  • Patients in whom placement of an ICE catheter in the cardiac space or the vessel is contraindicated or technically not feasible.
  • If femoral venous access is planned for ICE and IVC filter/IVC stent/iliac or femoral vein stent are present, an alternate access point should be used.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Mohamad Adnan Alkhouli, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions